Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1993 Jul;86(7):378–380.

Clobazam in the treatment of epilepsy: prospective follow-up to 8 years.

N Buchanan 1
PMCID: PMC1293003  PMID: 8371242

Full text

PDF
378

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dulac O., Figueroa D., Rey E., Arthuis M. Monothérapie par le clobazam dans les épilepsies de l'enfant. Presse Med. 1983 Apr 16;12(17):1067–1069. [PubMed] [Google Scholar]
  2. Feely M., Gibson J. Intermittent clobazam for catamenial epilepsy: tolerance avoided. J Neurol Neurosurg Psychiatry. 1984 Dec;47(12):1279–1282. doi: 10.1136/jnnp.47.12.1279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gastaut H., Low M. D. Antiepileptic properties of clobazam, a 1-5 benzodiazepine, in man. Epilepsia. 1979 Aug;20(4):437–446. doi: 10.1111/j.1528-1157.1979.tb04825.x. [DOI] [PubMed] [Google Scholar]
  4. Guberman A., Couture M., Blaschuk K., Sherwin A. Add-on trial of clobazam in intractable adult epilepsy with plasma level correlations. Can J Neurol Sci. 1990 Aug;17(3):311–316. doi: 10.1017/s031716710003064x. [DOI] [PubMed] [Google Scholar]
  5. Heller A. J., Ring H. A., Reynolds E. H. Factors relating to dramatic response to clobazam therapy in refractory epilepsy. Epilepsy Res. 1988 Jul-Aug;2(4):276–280. doi: 10.1016/0920-1211(88)90020-4. [DOI] [PubMed] [Google Scholar]
  6. Munn R., Camfield P., Camfield C., Dooley J. Clobazam for refractory childhood seizure disorders--a valuable supplementary drug. Can J Neurol Sci. 1988 Nov;15(4):406–408. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES